首页> 外文期刊>Pharmacognosy magazine >Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway
【24h】

Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway

机译:紫草素通过线粒体介导的途径诱导人胃癌细胞HGC-27凋亡

获取原文
       

摘要

Background:Gastric cancer (GC) is one of the most frequently occurring digestive tract cancers and fewer chemotherapeutic drugs for GC have shown promising results. In this study, we investigated the anti-tumor activity of shikonin, a natural compound isolated from the Chinese plant Lithospermum erythrorhizon, against the human GC cell line HGC-27.Materials and Methods:HGC-27 cells treated with shikonin at a concentration of 30μM or above showed significant growth inhibition compared to control cells. Shikonin-treated cells also underwent apoptosis as detected by flow cytometric analysis and microscopic examination of cellular morphology. Further investigation into the underlying mechanism of apoptosis by western blot showed that the shikonin promoted the activation of poly-(ADP-ribose)-polymerase, caspase-3 and caspase-9 following 24 h or 48 h of treatment time, as well as the activation of caspase-8, but only after 48 h of treatment time. Furthermore, the levels of mitochondrial membrane potential, B-cell lymphoma 2 (Bcl-2) and Bcl-extra large were reduced following shikonin treatment while the level of Bax was increased. In addition, shikonin also caused a significant reduction of the protein Survivin, while having little effect on the expression on X-linked inhibitor of apoptosis protein.Conclusion:Taken together, these results showed that the shikonin exhibited its anti-tumor activity against HGC-27 cells through inhibiting cell growth and promoting apoptosis by targeting mitochondrial-related signaling pathway. Our finding may represent a positive step in finding a natural and effective compound that could be important implication for future development of chemotherapeutic and/or chemopreventive agent against GC.
机译:背景:胃癌(GC)是最常见的消化道癌症之一,用于GC的化疗药物已显示出令人鼓舞的结果。在这项研究中,我们研究了紫草素(一种从中国植物紫草(Lithospermum erythrorhizon)植物中分离的天然化合物)对人GC细胞HGC-27的抗肿瘤活性。材料与方法:紫草素处理的HGC-27细胞浓度为与对照细胞相比,30μM或以上显示出明显的生长抑制。通过流式细胞术分析和细胞形态的显微镜检查,紫草素处理过的细胞也发生了凋亡。通过免疫印迹进一步研究细胞凋亡的潜在机制,发现紫草素在处理24小时或48小时后,促进了聚(ADP-核糖)-聚合酶,caspase-3和caspase-9的活化。 caspase-8活化,但仅在治疗48小时后。此外,紫草素处理后线粒体膜电位,B细胞淋巴瘤2(Bcl-2)和超大Bcl水平降低,而Bax水平升高。此外,紫草素还引起Survivin蛋白的显着减少,而对凋亡抑制蛋白的X连锁抑制剂的表达影响很小。 27种细胞通过靶向线粒体相关的信号传导途径抑制细胞生长并促进细胞凋亡。我们的发现可能代表寻找天然和有效化合物的积极步骤,这可能对未来针对GC的化学治疗和/或化学预防剂的发展具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号